Regional Medical Director - West

About Us  
Join us in helping patients with rare diseases. At Egetis Therapeutics we challenge the status quo for the benefit of those in need. We offer an open, positive and supportive culture where everyone can be their best. Through trust, we work seamlessly across functions. 
As an employee you are empowered and encouraged to have an entrepreneurial spirit, enjoying an organization with conscious and efficient decision-making and we take pride in our collaborative working environment!
In February 2025, the European Commission approved Egetis’ Emcitate® (tiratricol) as the first and only treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan-Herndon-Dudley syndrome). 
In March 2026, the U.S. FDA accepted the filing of Egetis’ New Drug Application (NDA) for Emcitate® (tiratricol) for the treatment of MCT8 deficiency and granted Priority Review. The Prescription Drug User Fee Act (PDUFA) target action date is September 28, 2026.  
As a courageous, committed, and collaborative organization, we are seeking to grow our team to drive success both in the pre-launch and post launch phases. For more information, please visit our website at www.egetis.com or follow us on LinkedIn and Facebook  

Our Values  
Courageous - Challenge the status quo for the benefit of the patient  
Committed - Operate with high ethical standards through an efficient organization to deliver top quality results
Collaborative - Through trust, work seamlessly across functions and with external partners 

About the Role
The Regional Medical Director (RMD) is a field-based medical/scientific expert responsible for delivering impactful medical education across a broad range of pediatric sub-specialty providers, including pediatric endocrinologists, pediatric neurologists, geneticists, and other clinicians who care for patients with rare and ultra-rare diseases. With a primary focus on developing durable external relationships and conducting fair and balanced scientific exchange with thought leaders (TLs) and healthcare professionals (HCPs), this position is central to a successful product launch and sustained post-launch engagement. The ideal candidate brings demonstrated experience launching therapies and will be instrumental to Egetis's efforts to bring new treatments to patients with rare and ultra-rare diseases while also supporting future pipeline programs and clinical trial execution.

• Prior experience supporting launch of therapies in the rare or ultra-rare disease space is strongly preferred. Candidates should understand the unique scientific, diagnostic, and stakeholder-engagement considerations associated with rare disease launches.
• 7+ years of experience in the biotechnology or pharmaceutical industry within Medical Affairs, including significant field medical experience.
• Extensive experience in rare or ultra-rare diseases required.
• Established relationships with healthcare professionals and thought leaders in pediatric endocrinology, pediatric neurology, clinical genetics, or neurogenetics are highly desirable.
• Demonstrated ability to build credible scientific relationships across multidisciplinary care teams, centers of excellence, and other stakeholders serving rare disease communities.
• Strong scientific communication and presentation skills, with demonstrated ability to communicate complex clinical and scientific information effectively to a range of internal and external stakeholders.
• Strong analytical skills, including the ability to critically evaluate and interpret scientific and clinical data and literature.
• Strong organizational skills, with the ability to prioritize effectively and operate independently in a field-based role.
• The ideal candidate has experience working in a small, entrepreneurial biotechnology or pharmaceutical organization and is energized by the opportunity to help build field medical capabilities, contribute beyond traditional role boundaries, and adapt as organizational needs evolve.
• Comfort operating with a high degree of ownership, agility, collaboration, and resourcefulness in a fast-paced environment with evolving priorities.
• Advanced scientific or clinical degree (e.g., MD, DO, PharmD, PhD, DNP, NP, or PA) or other relevant advanced healthcare qualification required, together with field medical experience appropriate for the role.

• As a key externally facing role, the RMD must commit to unwavering representation of Egetis’s mission as an ethical, high science, patient-focused company.  
• Develop and maintain clinical, scientific, and technical expertise in relevant product and disease state areas.  
• Conduct balanced medical/scientific exchange to educate health care providers (HCPs), thought leaders (TLs), payers and patient advocacy groups about Egetis’s clinical programs, to include disease state, diagnosis, mechanism of action, and data dissemination.  
• Assist cross-functional Medical Communication colleagues with development, review and approval of materials required for scientific exchange.  
• Contribute to development and execution of high-quality annual field medical strategic and operational plans, including HCP/TL engagement plans and congress plans.  
• Support company research initiatives across development at the request of Clinical to include, as examples: site evaluation and identification, recruitment, investigator meetings, external expert identification, accrual enhancement, and scientific and disease state education. May include support for training HCPs on appropriate administration of our products in the commercial setting, when appropriate.  
• Support the development and implementation of advisory boards and other scientific meetings as needed. 
• Monitor the competitive landscape for specific therapeutic areas of interest to Egetis, including current management strategies, approved products, new/emerging therapies, and differentiating features of approved/emerging competitor products. Contribute to CI plan for medical congresses.  Provide feedback internally on specific  initiatives.
• As part of scientific exchange with HCPs/TLs and resulting from a deep understanding of corporate and program goals, identify key insights and ensure internal stakeholders are informed, especially when those insights may support the successful execution of ongoing or planned clinical trials and the launch of therapies in rare and ultra-rare diseases.
• As necessary, assist with training Medical Affairs and other cross-functional colleagues on disease state, diagnosis, mechanism of action, and clinical trial data for Egetis programs. 
• Address unsolicited medical questions related to Egetis’s clinical programs and products in various forums e.g. regular scientific exchange, congress booths, ensuring timely, accurate and appropriate responses.  
• May be requested to support Medical Information as the function develops.  
• Support investigator-initiated research and grants through review, submission, evaluation, and recommendation of concepts/proposals
• Commit to unwavering compliance with Egetis’s policies and SOPs and with regulatory and other ethical guidelines relevant to the RMD role and the pharmaceutical industry.  
• Extensive travel consistent with RMD role, including occasional travel to the US office (Cambridge, MA) and the potential for some international travel.